Lilly’s decision to offer vials has also been seen as its way to combat the rise in compounding. Patients have been turning ...

Eli Lilly ( LLY -6.59%) is the most valuable healthcare stock in the world, with a market capitalization of around $720 ...

Eli Lilly's stock dipped due to cutting Q4 sales targets, despite a strong 2024 performance from Mounjaro and Zepbound. Click ...

If Eli Lilly continues to move lower, a bear put spread would be the best way to trade it. A bear put spread is a debit spread. That means we need to pay the premium to open the t ...

TD Cowen analyst Steve Scala reiterated a Buy rating on Eli Lilly & Co (LLY – Research Report) today and set a price target of $900.00.Stay ...

Eli Lilly has launched ... direct-to-consumer self-pay channel – are "at least 50% less than the list price of all other incretin medicines for obesity," claims Lilly. The new vials – priced ...

Eli Lilly is making a play for the idiopathic pulmonary fibrosis (IPF) market, offering Mediar Therapeutics $99 million in upfront and near-term payments for global rights to an asset that is ...

But while Ledbetter’s contributions toward the fight for equal pay are immortalized with the Lilly Ledbetter Fair Pay Act of 2009 (which essentially states that each unfair paycheck starts a new ...